Viewing Study NCT00248560


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-26 @ 12:38 AM
Study NCT ID: NCT00248560
Status: COMPLETED
Last Update Posted: 2019-03-05
First Post: 2005-11-03
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization: